Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivus Inc VVUSQ

Healthcare Biotechnology
VIVUS Inc is a US-based biopharmaceutical company engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. Its commercial products include Qsymia, an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index; PANCREAZE which is a is a pancreatic... see more

Recent & Breaking News (OTCPK:VVUSQ)

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Marketwired January 15, 2013

Surviving BioTech: How the Game is Played - Phase Funding, Drug Approvals and Resulting Revenue

PR Newswire January 14, 2013

Free Research Reports on AMZN, CREE, HMY and VVUS Issued by the Bedford Report

Marketwired January 8, 2013

Perfect Trade Setups, How to Play PPHM, VVUS, MDCI and CBMX

Marketwired January 8, 2013

Our Pros Knew GLUU, ARCO, NSM and VVUS Would Be Top Gainers on Friday

Marketwired January 7, 2013

The Real Story Behind LFVN, VVUS, ACTC and RAD

Marketwired January 7, 2013

VIVUS to Present at the 2013 JP Morgan Healthcare Conference

Troy Schwensen January 4, 2013

The Reason It Trades, What's Moving ALU, FTEK, RGR and VVUS

Marketwired December 20, 2012

VIVUS Announces Express Scripts Adds Qsymia (Phentermine And Topiramate Extended-Release) Capsules CIV To Its Standard Benefits Program

PR Newswire December 20, 2012